Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piotr Rutkowski

Showing results (191-200 of 491) with videos related to

Pageof 50
Sort By:
Tumori|March 15, 2017
Long-term results of therapy with sunitinib in metastatic alveolar soft part sarcomaPaulina Jagodzińska-Mucha, Tomasz Świtaj, Katarzyna Kozak, et al.
Journal of Cancer|March 28, 2018
IDH1/2 Mutations Predict Shorter Survival in ChondrosarcomaIwona Lugowska, Pawel Teterycz, Michal Mikula, et al.
Journal of Clinical Medicine|August 27, 2021
Age as a Prognostic Factor in Patients with Ewing Sarcoma-The Polish Sarcoma Group ExperiencePaulina Jagodzińska-Mucha, Anna Raciborska, Hanna Koseła-Paterczyk, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 24, 2021
Diagnosis strategy of adipocytic soft-tissue tumors in adults: a consensus from European expertsBenjamin Moulin, Christina Messiou, Amandine Crombe, et al.
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|May 23, 2017
[The long-term treatment outcomes of adult osteosarcoma]Iwowa Ługowska, Andrzej Pieńkowski, Anna Szumera-Ciećkiewicz, et al.
Oncology Letters|August 28, 2019
Prognostic value of the pretreatment neutrophil-to-lymphocyte ratio in patients with advanced gastrointestinal stromal tumors treated with sunitinib after imatinib failurePaweł Sobczuk, Paweł Teterycz, Iwona Lugowska, et al.
Therapeutic Advances in Medical Oncology|December 1, 2025
Identification of a novel <i>PRUNE2::NTRK2</i> gene fusion in soft tissue sarcoma patients-friend or foe? Case seriesKlaudia Bobak, Andrzej Tysarowski, Katarzyna A Seliga, et al.
Contemporary Oncology (Poznan, Poland)|November 12, 2015
The outcomes of Polish patients with advanced BRAF-positive melanoma treated with vemurafenib in a safety clinical trialPiotr Rutkowski, Katarzyna Kozak, Jacek Mackiewicz, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 19, 2014
Frequent mono-allelic loss associated with deficient PTEN expression in imatinib-resistant gastrointestinal stromal tumorsAnna Quattrone, Agnieszka Wozniak, Barbara Dewaele, et al.
Polish Journal of Pathology : Official Journal of the Polish Society of Pathologists|March 10, 2020
Pigmented/melanocytic malignant perivascular epithelioid cell tumor with TFE3-SFPQ(PSF) rearrangement - a challenging diagnosis of PEComa family of tumorsAnna Szumera-Cieækiewicz, Olga Kuczkiewicz-Siemion, Katarzyna Seliga, et al.
Pageof 50

Showing results (191-200 of 491) with videos related to

Sort By:
Pageof 50
Tumori|March 15, 2017
Long-term results of therapy with sunitinib in metastatic alveolar soft part sarcomaPaulina Jagodzińska-Mucha, Tomasz Świtaj, Katarzyna Kozak, et al.
Journal of Cancer|March 28, 2018
IDH1/2 Mutations Predict Shorter Survival in ChondrosarcomaIwona Lugowska, Pawel Teterycz, Michal Mikula, et al.
Journal of Clinical Medicine|August 27, 2021
Age as a Prognostic Factor in Patients with Ewing Sarcoma-The Polish Sarcoma Group ExperiencePaulina Jagodzińska-Mucha, Anna Raciborska, Hanna Koseła-Paterczyk, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 24, 2021
Diagnosis strategy of adipocytic soft-tissue tumors in adults: a consensus from European expertsBenjamin Moulin, Christina Messiou, Amandine Crombe, et al.
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|May 23, 2017
[The long-term treatment outcomes of adult osteosarcoma]Iwowa Ługowska, Andrzej Pieńkowski, Anna Szumera-Ciećkiewicz, et al.
Oncology Letters|August 28, 2019
Prognostic value of the pretreatment neutrophil-to-lymphocyte ratio in patients with advanced gastrointestinal stromal tumors treated with sunitinib after imatinib failurePaweł Sobczuk, Paweł Teterycz, Iwona Lugowska, et al.
Therapeutic Advances in Medical Oncology|December 1, 2025
Identification of a novel <i>PRUNE2::NTRK2</i> gene fusion in soft tissue sarcoma patients-friend or foe? Case seriesKlaudia Bobak, Andrzej Tysarowski, Katarzyna A Seliga, et al.
Contemporary Oncology (Poznan, Poland)|November 12, 2015
The outcomes of Polish patients with advanced BRAF-positive melanoma treated with vemurafenib in a safety clinical trialPiotr Rutkowski, Katarzyna Kozak, Jacek Mackiewicz, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 19, 2014
Frequent mono-allelic loss associated with deficient PTEN expression in imatinib-resistant gastrointestinal stromal tumorsAnna Quattrone, Agnieszka Wozniak, Barbara Dewaele, et al.
Polish Journal of Pathology : Official Journal of the Polish Society of Pathologists|March 10, 2020
Pigmented/melanocytic malignant perivascular epithelioid cell tumor with TFE3-SFPQ(PSF) rearrangement - a challenging diagnosis of PEComa family of tumorsAnna Szumera-Cieækiewicz, Olga Kuczkiewicz-Siemion, Katarzyna Seliga, et al.
Pageof 50